Genotypes of clinical varicella-zoster virus isolates from Manaus, Brazil
AUTOR(ES)
Bastos, Michele de Souza
FONTE
Rev. Soc. Bras. Med. Trop.
DATA DE PUBLICAÇÃO
16/05/2019
RESUMO
Abstract INTRODUCTION: Vaccination against varicella-zoster virus (VZV) has been effective and safe in countries that routinely administer the vaccine. Brazil began universal VZV vaccination in 2013. This study aimed to identify VZV genotypes present in Manaus, Brazil prior to widespread immunization. METHODS: Vesicular lesions or cerebral-spinal-fluid samples were collected from patients diagnosed with VZV, herpes zoster, or meningitis/encephalitis. DNA was extracted, amplified, and sequenced. RESULTS: Half the isolates were clade-5 viruses and the remaining were divided between the European clades 1 and 3. CONCLUSIONS: This study provides insights into the circulating VZV genotypes in Manaus prior to widespread vaccination.
Documentos Relacionados
- Analysis of the DNAs from seven varicella-zoster virus isolates.
- Varicella-zoster virus.
- Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity.
- Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.
- Structure of varicella-zoster virus DNA.